In recent years it has been supposed that impaired intestinal permeability represents an early event preceding the onset of inflammatory bowel disease (IBD). Since zonulin has been proposed as a biomarker of intestinal permeability, we investigated its role in patients with IBD and the correlation between serum and fecal zonulin.

Serum zonulin in patients with inflammatory bowel disease: a pilot study

Caviglia, Gian Paolo;DUGHERA, FRANCESCA;Ribaldone, Davide G;Rosso, Chiara;Abate, Maria L;Pellicano, Rinaldo;Smedile, Antonina;Saracco, Giorgio M;
2019-01-01

Abstract

In recent years it has been supposed that impaired intestinal permeability represents an early event preceding the onset of inflammatory bowel disease (IBD). Since zonulin has been proposed as a biomarker of intestinal permeability, we investigated its role in patients with IBD and the correlation between serum and fecal zonulin.
2019
110
95
100
Caviglia, Gian Paolo; Dughera, Francesca; Ribaldone, Davide G; Rosso, Chiara; Abate, Maria L; Pellicano, Rinaldo; Bresso, Francesca; Smedile, Antonina; Saracco, Giorgio M; Astegiano, Marco
File in questo prodotto:
File Dimensione Formato  
Minerva Med-5787_Manoscritto_V1_2018-07-16.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 202.26 kB
Formato Adobe PDF
202.26 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1679752
Citazioni
  • ???jsp.display-item.citation.pmc??? 42
  • Scopus 69
  • ???jsp.display-item.citation.isi??? 63
social impact